The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease

To identify rates of and risk factors for psychiatric diagnosis preceding the diagnosis of neurodegenerative disease. Systematic, retrospective, blinded chart review was performed of 252 patients with a neurodegenerative disease diagnosis seen in our specialty clinic between 1999 and 2008. Neurodege...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical psychiatry Vol. 72; no. 2; p. 126
Main Authors Woolley, Josh D, Khan, Baber K, Murthy, Nikhil K, Miller, Bruce L, Rankin, Katherine P
Format Journal Article
LanguageEnglish
Published United States 01.02.2011
Subjects
Online AccessGet more information

Cover

Loading…
Abstract To identify rates of and risk factors for psychiatric diagnosis preceding the diagnosis of neurodegenerative disease. Systematic, retrospective, blinded chart review was performed of 252 patients with a neurodegenerative disease diagnosis seen in our specialty clinic between 1999 and 2008. Neurodegenerative disease diagnoses included behavioral-variant frontotemporal dementia (n = 69), semantic dementia (n = 41), and progressive nonfluent aphasia (n = 17) (all meeting Neary research criteria); Alzheimer's disease (n = 65) (National Institute of Neurologic and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association research criteria); corticobasal degeneration (n = 25) (Boxer research criteria); progressive supranuclear palsy (n = 15) (Litvan research criteria); and amyotrophic lateral sclerosis (n = 20) (El Escorial research criteria). Reviewers remained blinded to each patient's final neurodegenerative disease diagnosis while reviewing charts. Extensive caregiver interviews were conducted to ensure accurate and reliable diagnostic histories. For each patient, we recorded history of psychiatric diagnosis, family psychiatric and neurologic history, age at symptom onset, and demographic information. A total of 28.2% of patients with a neurodegenerative disease received a prior psychiatric diagnosis. Depression was the most common psychiatric diagnosis in all groups. Behavioral-variant frontotemporal dementia patients received a prior psychiatric diagnosis significantly more often (50.7%; P < .001) than patients with Alzheimer's disease (23.1%), semantic dementia (24.4%), or progressive nonfluent aphasia (11.8%) and were more likely to receive diagnoses of bipolar disorder or schizophrenia than were patients with other neurodegenerative diseases (P < .001). Younger age (P < .001), higher education (P < .05), and a family history of psychiatric illness (P < .05) increased the rate of prior psychiatric diagnosis in patients with behavioral-variant frontotemporal dementia. Cognitive, behavioral, and emotional characteristics did not distinguish patients who did or did not receive a prior psychiatric diagnosis. Neurodegenerative disease is often misclassified as psychiatric disease, with behavioral-variant frontotemporal dementia patients at highest risk. While this study cannot rule out the possibility that psychiatric disease is an independent risk factor for neurodegenerative disease, when patients with neurodegenerative disease are initially classified with psychiatric disease, the patient may receive delayed, inappropriate treatment and be subject to increased distress. Physicians should consider referring mid- to late-life patients with new-onset neuropsychiatric symptoms for neurodegenerative disease evaluation.
AbstractList To identify rates of and risk factors for psychiatric diagnosis preceding the diagnosis of neurodegenerative disease. Systematic, retrospective, blinded chart review was performed of 252 patients with a neurodegenerative disease diagnosis seen in our specialty clinic between 1999 and 2008. Neurodegenerative disease diagnoses included behavioral-variant frontotemporal dementia (n = 69), semantic dementia (n = 41), and progressive nonfluent aphasia (n = 17) (all meeting Neary research criteria); Alzheimer's disease (n = 65) (National Institute of Neurologic and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association research criteria); corticobasal degeneration (n = 25) (Boxer research criteria); progressive supranuclear palsy (n = 15) (Litvan research criteria); and amyotrophic lateral sclerosis (n = 20) (El Escorial research criteria). Reviewers remained blinded to each patient's final neurodegenerative disease diagnosis while reviewing charts. Extensive caregiver interviews were conducted to ensure accurate and reliable diagnostic histories. For each patient, we recorded history of psychiatric diagnosis, family psychiatric and neurologic history, age at symptom onset, and demographic information. A total of 28.2% of patients with a neurodegenerative disease received a prior psychiatric diagnosis. Depression was the most common psychiatric diagnosis in all groups. Behavioral-variant frontotemporal dementia patients received a prior psychiatric diagnosis significantly more often (50.7%; P < .001) than patients with Alzheimer's disease (23.1%), semantic dementia (24.4%), or progressive nonfluent aphasia (11.8%) and were more likely to receive diagnoses of bipolar disorder or schizophrenia than were patients with other neurodegenerative diseases (P < .001). Younger age (P < .001), higher education (P < .05), and a family history of psychiatric illness (P < .05) increased the rate of prior psychiatric diagnosis in patients with behavioral-variant frontotemporal dementia. Cognitive, behavioral, and emotional characteristics did not distinguish patients who did or did not receive a prior psychiatric diagnosis. Neurodegenerative disease is often misclassified as psychiatric disease, with behavioral-variant frontotemporal dementia patients at highest risk. While this study cannot rule out the possibility that psychiatric disease is an independent risk factor for neurodegenerative disease, when patients with neurodegenerative disease are initially classified with psychiatric disease, the patient may receive delayed, inappropriate treatment and be subject to increased distress. Physicians should consider referring mid- to late-life patients with new-onset neuropsychiatric symptoms for neurodegenerative disease evaluation.
Author Rankin, Katherine P
Woolley, Josh D
Murthy, Nikhil K
Khan, Baber K
Miller, Bruce L
Author_xml – sequence: 1
  givenname: Josh D
  surname: Woolley
  fullname: Woolley, Josh D
  email: Josh.Woolley@ucsf.edu
  organization: Langley Porter, Department of Psychiatry, University of California, San Francisco, USA. Josh.Woolley@ucsf.edu
– sequence: 2
  givenname: Baber K
  surname: Khan
  fullname: Khan, Baber K
– sequence: 3
  givenname: Nikhil K
  surname: Murthy
  fullname: Murthy, Nikhil K
– sequence: 4
  givenname: Bruce L
  surname: Miller
  fullname: Miller, Bruce L
– sequence: 5
  givenname: Katherine P
  surname: Rankin
  fullname: Rankin, Katherine P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21382304$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1OwzAQhS0EoqWwZod8gZRxnDQuO1Txq0qwKOvKccaNIbEj2wXlaNyOFIrEhs2Mnt7M9zRzQg6ts0jIOYNpBkJcPi6epwxamHGRusYckDHL8zxJGbAROQnhFQBmBfBjMkrZMMMhG5PPVY20MnJjXYhGUVXLpkG7Qeo07UKvaiOjH4zQt110baDGUotb7yrcoEUvo3nfEQLKgFd00Bh2u9JW1JvwRrVU0flAtfO082ZX_2D30eab2w0wtDHQDxNritI3_f9Zp-RIyybg2b5PyMvtzWpxnyyf7h4W18tEccFiMhd5qYTIOAjNBWRVVYJiMBcir2ZaDXKeFTKTWihABCUZLwsUrFC81JDqdEIufrjdtmyxWg83tNL3698fpl97BXsc
CitedBy_id crossref_primary_10_1016_j_eurpsy_2017_06_008
crossref_primary_10_1016_j_biopsych_2014_01_020
crossref_primary_10_1017_cjn_2022_69
crossref_primary_10_3389_fnagi_2024_1382593
crossref_primary_10_3389_fpsyt_2022_1046471
crossref_primary_10_1016_j_jagp_2015_04_002
crossref_primary_10_1016_j_osep_2024_10_003
crossref_primary_10_1080_13854046_2023_2181223
crossref_primary_10_1177_0004867419857811
crossref_primary_10_3390_brainsci8090177
crossref_primary_10_1016_j_jagp_2019_12_007
crossref_primary_10_2174_1570159X20666220706110157
crossref_primary_10_1016_j_cortex_2022_02_018
crossref_primary_10_1016_j_jagp_2016_06_011
crossref_primary_10_3390_ph16091295
crossref_primary_10_1016_j_jpsychires_2019_03_019
crossref_primary_10_1136_practneurol_2020_002730
crossref_primary_10_1002_alz_12299
crossref_primary_10_1017_S1041610223000030
crossref_primary_10_1016_j_jagp_2015_04_007
crossref_primary_10_1176_appi_neuropsych_16090168
crossref_primary_10_1016_j_biopsych_2015_03_028
crossref_primary_10_1016_j_tice_2022_101758
crossref_primary_10_3389_fnmol_2022_984317
crossref_primary_10_1016_j_jns_2022_120439
crossref_primary_10_3389_fneur_2019_00594
crossref_primary_10_3109_09540261_2013_776949
crossref_primary_10_4103_jgmh_jgmh_48_23
crossref_primary_10_1212_WNL_0000000000004494
crossref_primary_10_1186_s13550_023_01020_2
crossref_primary_10_1177_08919887231164357
crossref_primary_10_1016_j_biopha_2022_112924
crossref_primary_10_1016_j_ncl_2017_01_008
crossref_primary_10_1192_bjo_2019_36
crossref_primary_10_3389_fpsyt_2021_782183
crossref_primary_10_3390_diagnostics11050754
crossref_primary_10_3109_09540261_2012_743877
crossref_primary_10_1159_000441023
crossref_primary_10_3389_fneur_2021_683162
crossref_primary_10_1136_jnnp_2022_330152
crossref_primary_10_3390_healthcare12050576
crossref_primary_10_1055_a_2052_8462
crossref_primary_10_1159_000443205
crossref_primary_10_1016_j_jagp_2023_02_006
crossref_primary_10_1159_000440859
crossref_primary_10_1177_0891988714554710
crossref_primary_10_1002_alz_14363
crossref_primary_10_1101_cshperspect_a033118
crossref_primary_10_2217_nmt_14_34
crossref_primary_10_1177_0891988716654986
crossref_primary_10_1111_ene_15837
crossref_primary_10_1038_s41572_023_00447_0
crossref_primary_10_1166_jbmb_2021_2105
crossref_primary_10_1097_NRL_0000000000000527
crossref_primary_10_1176_appi_neuropsych_21110269
crossref_primary_10_53841_bpsfpop_2018_1_142_26
crossref_primary_10_1016_j_neures_2016_12_004
crossref_primary_10_1002_gps_5368
crossref_primary_10_1016_j_cortex_2021_03_006
crossref_primary_10_1002_trc2_12069
crossref_primary_10_1002_alz_13129
crossref_primary_10_1212_WNL_0000000000004248
crossref_primary_10_3233_JAD_215516
crossref_primary_10_1177_08919887221119976
crossref_primary_10_1111_bdi_12387
crossref_primary_10_1186_s12913_019_4603_2
crossref_primary_10_3390_microorganisms11082042
crossref_primary_10_1016_j_jalz_2015_05_017
crossref_primary_10_1093_brain_awab365
crossref_primary_10_1177_08919887211036189
crossref_primary_10_1212_WNL_0b013e318293e368
crossref_primary_10_31363_2313_7053_2024_853
crossref_primary_10_1016_j_jad_2019_03_024
crossref_primary_10_1016_j_ymeth_2020_09_007
crossref_primary_10_1016_j_psiq_2016_06_001
crossref_primary_10_1002_gps_5253
crossref_primary_10_4103_0028_3886_329621
crossref_primary_10_1111_psyg_12874
crossref_primary_10_1177_0004867418815976
crossref_primary_10_3233_JAD_170608
crossref_primary_10_1016_j_jagp_2022_03_006
crossref_primary_10_1111_pcn_13810
crossref_primary_10_1007_s10072_022_06056_1
crossref_primary_10_1016_j_neubiorev_2020_08_002
crossref_primary_10_1016_j_nicl_2015_07_017
crossref_primary_10_1007_s11357_020_00304_y
crossref_primary_10_1016_j_nicl_2018_08_028
crossref_primary_10_1016_j_biopsych_2014_12_031
crossref_primary_10_1212_CON_0000000000000698
crossref_primary_10_3233_JAD_180528
crossref_primary_10_1080_07317115_2021_1873881
crossref_primary_10_1016_j_jns_2021_120088
crossref_primary_10_1016_j_neurop_2024_100179
crossref_primary_10_1038_s41398_024_03073_w
crossref_primary_10_1111_ene_16426
crossref_primary_10_1177_1039856219860031
crossref_primary_10_1002_acn3_330
crossref_primary_10_3390_ijms242115797
crossref_primary_10_1186_s12883_017_1008_x
crossref_primary_10_1007_s11910_019_1017_9
crossref_primary_10_1007_s40533_013_0001_y
crossref_primary_10_1080_13554794_2016_1187178
crossref_primary_10_1097_WAD_0000000000000441
crossref_primary_10_1016_j_jaclp_2021_01_001
crossref_primary_10_3389_fnagi_2023_1298307
crossref_primary_10_1111_ene_14247
crossref_primary_10_1016_j_bbadis_2020_165752
crossref_primary_10_3109_09540261_2013_769939
crossref_primary_10_1177_08919887231195234
crossref_primary_10_1371_journal_pmen_0000107
crossref_primary_10_1002_dad2_12471
crossref_primary_10_1176_appi_neuropsych_13020031
crossref_primary_10_1002_alz_12898
crossref_primary_10_1177_14713012221077531
crossref_primary_10_1016_j_neurol_2015_04_008
crossref_primary_10_1136_jnnp_2017_317263
crossref_primary_10_3389_fneur_2021_729381
crossref_primary_10_7334_psicothema2023_40
crossref_primary_10_1080_15528030_2020_1773372
crossref_primary_10_1097_01_XME_0000415592_81690_e8
crossref_primary_10_3233_JAD_230779
crossref_primary_10_1097_YCO_0000000000000979
crossref_primary_10_1016_j_jalz_2019_08_199
crossref_primary_10_1111_jgs_19211
crossref_primary_10_3233_JAD_160285
crossref_primary_10_3389_fnins_2021_689938
crossref_primary_10_1017_S0033291718003604
crossref_primary_10_2174_1573400515666190617154129
crossref_primary_10_1071_AH23253
crossref_primary_10_1080_03007995_2016_1277197
crossref_primary_10_1176_appi_neuropsych_20100266
crossref_primary_10_1016_S0140_6736_15_00461_4
crossref_primary_10_1016_j_psc_2015_02_001
crossref_primary_10_1177_00048674211041003
crossref_primary_10_1177_02537176241236035
crossref_primary_10_1007_s00415_021_10714_3
crossref_primary_10_2174_1389203721999201208200605
crossref_primary_10_1016_j_psc_2020_02_005
crossref_primary_10_3389_fpsyt_2021_768722
crossref_primary_10_1159_000507544
crossref_primary_10_3389_fneur_2021_713388
crossref_primary_10_5937_mp69_16325
crossref_primary_10_3233_JAD_191333
crossref_primary_10_1016_j_jagp_2023_08_017
crossref_primary_10_1136_jnnp_2021_326487
crossref_primary_10_1007_s00415_019_09567_8
crossref_primary_10_1002_gps_5843
crossref_primary_10_1186_alzrt141
crossref_primary_10_3389_fneur_2022_877143
crossref_primary_10_1080_13607863_2021_2008871
crossref_primary_10_1016_j_biopsych_2013_11_006
crossref_primary_10_1017_cjn_2023_248
crossref_primary_10_1080_14737175_2025_2461758
crossref_primary_10_1111_1747_0080_12144
crossref_primary_10_1186_s13024_017_0163_2
crossref_primary_10_1177_08919887231195337
crossref_primary_10_1016_j_cortex_2018_02_012
crossref_primary_10_1159_000444849
crossref_primary_10_3233_JAD_160860
crossref_primary_10_1177_0706743716648296
crossref_primary_10_3389_fneur_2020_00446
crossref_primary_10_3233_ADR_210294
crossref_primary_10_1586_ern_12_46
crossref_primary_10_2174_1871527322666230519113201
crossref_primary_10_1093_brain_awac133
crossref_primary_10_1176_appi_focus_20200007
crossref_primary_10_1080_13554794_2021_1905855
crossref_primary_10_1177_0891988713490992
crossref_primary_10_1016_j_lpmfor_2022_01_015
crossref_primary_10_1017_S1041610217001880
crossref_primary_10_17116_jnevro202212203159
crossref_primary_10_3233_JAD_230877
crossref_primary_10_1007_s00415_013_6833_2
crossref_primary_10_1177_1755738020910779
crossref_primary_10_1097_YPG_0000000000000118
crossref_primary_10_1186_s12877_023_04268_4
crossref_primary_10_1590_0004_282x20190107
crossref_primary_10_4103_aip_aip_175_23
crossref_primary_10_1111_ggi_14722
crossref_primary_10_3389_fneur_2021_750543
crossref_primary_10_1002_alz_12643
crossref_primary_10_3389_fnagi_2023_1273855
crossref_primary_10_1097_01_XME_0000407866_00571_95
crossref_primary_10_1016_j_pharmthera_2025_108823
crossref_primary_10_3233_JAD_160979
crossref_primary_10_1093_braincomms_fcad321
crossref_primary_10_3233_JAD_210254
crossref_primary_10_1097_WAD_0000000000000526
crossref_primary_10_3389_fneur_2021_710332
crossref_primary_10_1016_j_biopha_2024_117652
crossref_primary_10_3233_JAD_190981
crossref_primary_10_3390_brainsci14121171
crossref_primary_10_3390_healthcare12040485
crossref_primary_10_1080_02687038_2019_1568135
crossref_primary_10_30629_2618_6667_2023_21_7_76_96
crossref_primary_10_1146_annurev_clinpsy_032813_153653
crossref_primary_10_1016_j_psc_2015_01_002
crossref_primary_10_3233_JAD_180131
crossref_primary_10_1016_j_ijlp_2016_04_001
crossref_primary_10_1080_13554794_2021_1918723
crossref_primary_10_1177_00048674231187312
crossref_primary_10_1177_1550059417750914
crossref_primary_10_1186_s13195_020_00753_9
crossref_primary_10_3390_healthcare12030313
crossref_primary_10_1212_WNL_0000000000209569
crossref_primary_10_1017_S1041610217001855
crossref_primary_10_1186_s13195_024_01512_w
crossref_primary_10_7759_cureus_11613
crossref_primary_10_1016_j_jpsychires_2022_10_071
crossref_primary_10_1007_s11920_016_0700_7
crossref_primary_10_1177_1039856218762308
crossref_primary_10_1017_S135561772100045X
crossref_primary_10_1016_j_jpsychires_2018_07_014
crossref_primary_10_1016_j_jagp_2012_08_020
crossref_primary_10_1017_S1041610220001489
crossref_primary_10_1007_s13670_018_0240_6
crossref_primary_10_1111_ene_70036
crossref_primary_10_1007_s00702_021_02426_9
crossref_primary_10_1002_dad2_12027
crossref_primary_10_1590_0004_282x_anp_2022_s140
crossref_primary_10_3233_JAD_180700
crossref_primary_10_3389_fpsyt_2018_00739
crossref_primary_10_1007_s12474_019_00234_2
crossref_primary_10_1016_j_praneu_2021_03_014
crossref_primary_10_1080_14737159_2020_1731306
crossref_primary_10_1097_HRP_0000000000000143
crossref_primary_10_1136_jnnp_2020_325994
crossref_primary_10_3233_JAD_201184
crossref_primary_10_3389_fnins_2021_725547
crossref_primary_10_3389_fpsyt_2022_898023
crossref_primary_10_3233_JAD_170797
crossref_primary_10_7759_cureus_27750
crossref_primary_10_36290_psy_2022_002
crossref_primary_10_1017_S1355617712000604
crossref_primary_10_1177_1533317519853466
crossref_primary_10_1002_alz_12549
crossref_primary_10_3233_JAD_230829
crossref_primary_10_1177_14713012211009340
crossref_primary_10_1007_s15202_016_1056_x
crossref_primary_10_1024_1662_9647_a000126
crossref_primary_10_1177_1533317514524811
crossref_primary_10_1097_WAD_0000000000000181
crossref_primary_10_7759_cureus_72912
crossref_primary_10_1080_17470919_2016_1245214
crossref_primary_10_1111_brv_12626
crossref_primary_10_1016_j_schres_2020_11_049
crossref_primary_10_3233_JAD_190278
crossref_primary_10_1038_s41380_020_0766_9
crossref_primary_10_1093_milmed_usae161
crossref_primary_10_1111_jnc_13654
crossref_primary_10_1007_s10897_016_0056_5
crossref_primary_10_1007_s11910_012_0302_7
crossref_primary_10_1016_j_euroneuro_2018_11_677
crossref_primary_10_1212_NXI_0000000000000301
crossref_primary_10_1176_appi_ajp_2015_14101248
crossref_primary_10_1177_1471301220988231
crossref_primary_10_3109_09540261_2013_763341
crossref_primary_10_1016_j_psym_2011_04_005
crossref_primary_10_3233_JAD_210688
crossref_primary_10_3390_ijerph21020231
crossref_primary_10_1002_brb3_2896
crossref_primary_10_1016_j_jagp_2013_02_002
crossref_primary_10_31363_2313_7053_2018_2_109_115
crossref_primary_10_1002_cam4_850
crossref_primary_10_1007_s44345_024_00004_6
crossref_primary_10_1111_acps_13362
crossref_primary_10_1038_s41380_018_0133_2
crossref_primary_10_1016_j_rmclc_2020_02_001
crossref_primary_10_1007_s00232_017_9998_2
crossref_primary_10_1016_j_biopsych_2022_05_028
crossref_primary_10_1177_1039856221992643
crossref_primary_10_3389_fpsyt_2024_1449526
crossref_primary_10_1080_07317115_2014_907595
crossref_primary_10_1093_brain_awv344
crossref_primary_10_1017_S1355617723000619
crossref_primary_10_1186_s13195_024_01409_8
crossref_primary_10_37586_2686_8636_3_2020_217_224
crossref_primary_10_1017_cjn_2016_25
crossref_primary_10_1016_j_cobeha_2018_01_022
crossref_primary_10_3389_fnins_2024_1491972
crossref_primary_10_1002_gps_5424
crossref_primary_10_3390_medicina59122155
crossref_primary_10_1159_000438454
crossref_primary_10_2174_0118746098243327231117113748
crossref_primary_10_3233_JAD_180053
crossref_primary_10_51338_rppsm_394
crossref_primary_10_2165_11640070_000000000_00000
crossref_primary_10_3389_fnins_2018_00933
crossref_primary_10_1093_brain_awaa018
crossref_primary_10_1016_j_psychres_2014_11_029
crossref_primary_10_1177_0891988720915515
crossref_primary_10_1136_jnnp_2015_310697
crossref_primary_10_3389_fneur_2021_768591
crossref_primary_10_1177_14713012231191958
crossref_primary_10_1212_CPJ_0000000000200360
crossref_primary_10_1016_j_ejphar_2012_10_032
crossref_primary_10_1017_S1041610223000236
crossref_primary_10_3109_09540261_2013_766154
crossref_primary_10_1007_s00702_021_02455_4
crossref_primary_10_1017_S1041610214002580
crossref_primary_10_1017_S1041610217001260
crossref_primary_10_1590_1980_57642018dn12_010011
crossref_primary_10_1159_000369882
crossref_primary_10_1212_WNL_0000000000004179
crossref_primary_10_1080_13554794_2021_1984539
crossref_primary_10_1186_s12913_024_11680_y
crossref_primary_10_1134_S0362119720080137
crossref_primary_10_1016_j_genhosppsych_2011_09_019
crossref_primary_10_1016_j_neurobiolaging_2020_08_018
crossref_primary_10_1176_appi_neuropsych_20010003
crossref_primary_10_1177_00048674241312805
crossref_primary_10_1024_1662_9647_a000331
crossref_primary_10_1111_psyg_12898
crossref_primary_10_1177_0706743716672409
crossref_primary_10_1177_08919887221130267
crossref_primary_10_1016_j_dadm_2017_01_009
crossref_primary_10_1007_s11055_022_01326_z
crossref_primary_10_1016_j_bbih_2022_100498
crossref_primary_10_3233_JAD_180839
crossref_primary_10_1017_S1041610222001259
crossref_primary_10_1186_s13195_019_0503_2
crossref_primary_10_1111_neup_12441
crossref_primary_10_1177_16094069221081377
crossref_primary_10_1017_neu_2023_25
crossref_primary_10_12968_bjon_2012_21_12_723
crossref_primary_10_1155_2012_275957
crossref_primary_10_1177_16094069231176195
crossref_primary_10_1186_s12877_024_04988_1
crossref_primary_10_1038_nrn3229
crossref_primary_10_1176_appi_neuropsych_21060166
crossref_primary_10_1155_2012_463909
crossref_primary_10_1016_j_rcp_2022_06_002
crossref_primary_10_1111_bdi_12984
crossref_primary_10_1017_S1041610218001242
crossref_primary_10_1002_gps_5692
crossref_primary_10_1177_21677026221141852
crossref_primary_10_3389_fneur_2014_00071
crossref_primary_10_3389_fneur_2021_707799
crossref_primary_10_1177_0271678X241262583
crossref_primary_10_1016_j_pnpbp_2019_04_008
crossref_primary_10_1176_appi_neuropsych_20230041
crossref_primary_10_3390_ijms22094440
crossref_primary_10_1007_s00415_023_11666_6
crossref_primary_10_1176_appi_neuropsych_20090238
crossref_primary_10_1136_bmjopen_2023_081935
crossref_primary_10_3233_JAD_210090
crossref_primary_10_3233_JAD_151198
crossref_primary_10_1016_j_neuropsychologia_2017_02_012
crossref_primary_10_1055_s_0040_1716805
crossref_primary_10_2174_1385272823666190327100418
crossref_primary_10_1017_S1041610217000953
crossref_primary_10_7554_eLife_86085
ContentType Journal Article
Copyright Copyright 2011 Physicians Postgraduate Press, Inc.
Copyright_xml – notice: Copyright 2011 Physicians Postgraduate Press, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.4088/JCP.10m06382oli
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1555-2101
ExternalDocumentID 21382304
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA094143
– fundername: NIMH NIH HHS
  grantid: R25 MH060482
– fundername: NIA NIH HHS
  grantid: P01 AG017586
– fundername: NIA NIH HHS
  grantid: 5-P01 AG19724
– fundername: NIA NIH HHS
  grantid: P01 AG019724
– fundername: NIA NIH HHS
  grantid: P50 AG023501
GroupedDBID ---
.55
.GJ
0R~
1VV
1X7
3O-
53G
5GY
5RE
85S
AAIKC
AAJMC
AAMNW
AAQQT
AAUPJ
AAWTO
ABCQX
ABIVO
ABJNI
ABPPZ
ACALU
ACBNA
ACGFO
ACGFS
ACHQT
ACNCT
ADCOW
AENEX
AFFNX
AFOSN
AI.
AIZTS
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
EBS
ECM
EIF
EJD
F5P
FA8
HZ~
H~9
J5H
L7B
NEJ
NPM
O9-
OHT
P0W
P2P
PQQKQ
SJN
UHB
VH1
WH7
X7M
ZCA
ZGI
ZXP
ID FETCH-LOGICAL-c381t-985bc884308f3804ddb0c109885d6fcddb947a4af8c0ee0ca13b7e817c3bf02f2
IngestDate Sat May 31 02:06:28 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Copyright 2011 Physicians Postgraduate Press, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c381t-985bc884308f3804ddb0c109885d6fcddb947a4af8c0ee0ca13b7e817c3bf02f2
PMID 21382304
ParticipantIDs pubmed_primary_21382304
PublicationCentury 2000
PublicationDate 2011-02-01
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The journal of clinical psychiatry
PublicationTitleAlternate J Clin Psychiatry
PublicationYear 2011
References 32780916 - Bipolar Disord. 2020 Nov;22(7):761-763. doi: 10.1111/bdi.12984.
References_xml – reference: 32780916 - Bipolar Disord. 2020 Nov;22(7):761-763. doi: 10.1111/bdi.12984.
SSID ssj0006703
Score 2.5133185
Snippet To identify rates of and risk factors for psychiatric diagnosis preceding the diagnosis of neurodegenerative disease. Systematic, retrospective, blinded chart...
SourceID pubmed
SourceType Index Database
StartPage 126
SubjectTerms Adjustment Disorders - diagnosis
Adjustment Disorders - epidemiology
Adjustment Disorders - genetics
Adjustment Disorders - psychology
Age of Onset
Aged
Anxiety Disorders - diagnosis
Anxiety Disorders - epidemiology
Anxiety Disorders - genetics
Anxiety Disorders - psychology
Bipolar Disorder - diagnosis
Bipolar Disorder - epidemiology
Bipolar Disorder - genetics
Bipolar Disorder - psychology
Comorbidity
Cross-Sectional Studies
Depressive Disorder, Major - diagnosis
Depressive Disorder, Major - psychology
Female
Genetic Predisposition to Disease - genetics
Humans
Male
Mental Disorders - diagnosis
Mental Disorders - epidemiology
Mental Disorders - genetics
Mental Disorders - psychology
Middle Aged
Neurocognitive Disorders - diagnosis
Neurocognitive Disorders - epidemiology
Neurocognitive Disorders - genetics
Neurocognitive Disorders - psychology
Neurodegenerative Diseases - diagnosis
Neurodegenerative Diseases - epidemiology
Neurodegenerative Diseases - genetics
Neurodegenerative Diseases - psychology
Retrospective Studies
Risk Factors
Schizophrenia - diagnosis
Schizophrenia - epidemiology
Schizophrenia - genetics
Schizophrenic Psychology
Title The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease
URI https://www.ncbi.nlm.nih.gov/pubmed/21382304
Volume 72
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2ICEuiHdpAfnANSUPO3G4lQpUgVpxaKXeKtux2YjuQyUc2n_W_9QfwYztJN6FRcAl2o03dnbn0-x48s03hLypLTesLFgileIJM1WZ1JKLpMlkoVBxzTidgqPj8vCUfTrjZ5PJbcRa-tGpPX3927qS_7EqnAO7YpXsP1h2mBROwGuwLxzBwnD8axs3niuHuqu6b4yyQmOGge9Xs2W3mDnqqxOwbMxXJzfteEPhGQ3mBlA3wnE7BtZ5348H2YjLyxaP0cRh8daT0b1Ea6iXM045eeNqcVCMXyNSsBiKNVeZ2J5AjHmOq_DoYjrSlT9PfSL3vVTmckzdAow6D6Pj9tu0vYhGhhpIh-5QfNGM-dyBSmKCy-Y8gY1rFvv0Ko-wm0cOOvP1-et_HAycLfbEPviyl6UzDOPyxUUbfxKMsJw5HOUo21j4psl_Hl1T8u6HtsgW7GmwSStmlkLUUILr9dJTeC9v1-7EaVb7q9f2Py4OOnlIHoQNDN33aHxEJmb-mNw7ChSNJ-QGrElHUNIBlHRhaYQd2oOStnP6C0xogMk76iCJ1wIkKUKSBkhSgCR1kFyZdoAkzttDkiIkqYPk5rWektOPH04ODpPQHyTREGd2SS240kKwIhW2EClrGpXqLK2F4E1pNbytWSWZtEKnxqRaZuB-jMgqXSib5jZ_Ru7MF3OzTajNU1VZlC6qDavqRuaF1IzbUuVNUXL-gjz3P_r50ovAnPfm2Nk4skvuj4B9Se5a8DrmFYSwnXrtbP8To2Gpsw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+diagnostic+challenge+of+psychiatric+symptoms+in+neurodegenerative+disease%3A+rates+of+and+risk+factors+for+prior+psychiatric+diagnosis+in+patients+with+early+neurodegenerative+disease&rft.jtitle=The+journal+of+clinical+psychiatry&rft.au=Woolley%2C+Josh+D&rft.au=Khan%2C+Baber+K&rft.au=Murthy%2C+Nikhil+K&rft.au=Miller%2C+Bruce+L&rft.date=2011-02-01&rft.eissn=1555-2101&rft.volume=72&rft.issue=2&rft.spage=126&rft_id=info:doi/10.4088%2FJCP.10m06382oli&rft_id=info%3Apmid%2F21382304&rft_id=info%3Apmid%2F21382304&rft.externalDocID=21382304